News
Research highlights the potential risks of antiepileptic drugs during pregnancy, including teratogenicity and ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Revisions to classification criteria ‘will ensure homogeneous trial populations’ with data-driven scoring, a standardized MRI ...
Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative ...
Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.
Adds nine additional countries to the Company’s ongoing pivotal Phase 3 trial; Authorization granted in all EU countries ...
1d
GlobalData on MSNAre regulators keeping pace with AI adoption in clinical trials?AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, ...
Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...
1d
Pharmaceutical Technology on MSNAGC Biologics and Quell to progress Treg cell therapy developmentAGC Biologics has collaborated with Quell Therapeutics to advance the development of several T-regulatory (Treg) cell therapy ...
The PDCO's positive opinion is based on PolTREG's original preTreg clinical trial protocol initiated in October 2024, which enrolled children aged 6-16 years in Stage 1 type 1 diabetes. In its ...
Topline results were released from the phase 3 MAPLE-HCM trial, which compared aficamten with metoprolol in 175 adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results